e-learning
resources
Paris 2018
Sunday, 16.09.2018
Cardiovascular morbidities in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk factors for asymptomatic atrial fibrillation in patients with COPD
E. Samorukova (Moscow, Russian Federation), E. Leonova (Moscow, Russian Federation), T. Adasheva (Moscow, Russian Federation), V. Zadionchenko (Moscow, Russian Federation), A. Malyavin (Moscow, Russian Federation), S. Pavlov (Moscow, Russian Federation)
Source:
International Congress 2018 – Cardiovascular morbidities in COPD
Session:
Cardiovascular morbidities in COPD
Session type:
Thematic Poster
Number:
744
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Samorukova (Moscow, Russian Federation), E. Leonova (Moscow, Russian Federation), T. Adasheva (Moscow, Russian Federation), V. Zadionchenko (Moscow, Russian Federation), A. Malyavin (Moscow, Russian Federation), S. Pavlov (Moscow, Russian Federation). Risk factors for asymptomatic atrial fibrillation in patients with COPD. 744
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Risk factors for new-onset atrial fibrillation in patients with asthma-COPD overlap syndrome (ACOS)
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
OSA and atrial fibrillation
Source: Sleep and Breathing Conference 2021
Year: 2021
Prevalence and clinical predictors of sleep apnea in patients with paroxysmal atrial fibrillation
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Inflammatory pathways in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation
Source: Eur Respir J 2007; 30: Suppl. 51, 707s
Year: 2007
Atrial fibrillation and stroke risk in relation to COPD and chronic productive cough
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006
Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
The role of interleukin 6 on incident atrial fibrillation in COPD patients
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Atrial fibrillation in critical care patients with respiratory failure: Incidence and clinical effects
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012
Risk factors for non-compliance with continuous positive airway pressure therapy in patients with obstructive sleep apnea and paroxysmal atrial fibrillation
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Evaluation of a new cardiac arrhythmias predictor in patients with COPD
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Is COPD a risk factor for electrocardiographic abnormalities and cardiac arrhythmias?
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
Unexpected high prevalence of left ventricular cardiopathy in patients with COPD
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Assessment of atrial arrhythmogenic risk factors with body surface potential mapping in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005
Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018
Atrial fibrillation is not a predictor of in-hospital mortality in pulmonary embolism
Source: Eur Respir J 2007; 30: Suppl. 51, 80s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept